Member Info for EmeraldCarrots

Nearly FOUR MONTHS ago. See here:-

https://www.lse.co.uk/rns/GDR/breakthrough-device-designation-from-the-us-fda-2zclfstav7guqaq.html

. So was that a 750,000 share buy @ 8p?

Can one complain about the MM's to the FCA? I think the MM is Peel Hunt.

Bye.

It can't be from 10:43.01 today. The bid is the lowest price the mm's can offer. Maybe from yesterday IMHO.

FFS! The sp is UP, not down 4.21%. The mm's have screwed up the % because of the ultra weird uncrossing trade at close of play yesterday. The bid at close yesterday was 2.15p, now it's 2.2p so how is the sp DOWN??????????????? A joke.

Bid ticked up to 2.2p, ask is 2.35p and getting it.

Spread back to the real workd now it seems.

A couple of small buys @ 2.32p, when the bid, at least as shown is 2.15p. Very odd.

TrickyEFC

The ut yesterday to make it look down today when it ain't.

Mms want ya shares

================

Not impressed with the MM's here.

You are right the bid today is same as yesterday but it shows 5.26% DOWN.

Also the bid should be 2.2p and the ask 2.3p.......... look at the trades.

Never known anything like it.......

All IMHO.

Actual bid is 2.2p, ask 2.3p IMHO. What are they doing?

Again.

Yes, we will find out tomorrow morning for sure. On the bright side it could be a huge buy that has not been disclosed yet. Note extremely large buys/sells do NOT have to be disclosed (shown) for up to ten days. The bid price will however reflect even an undisclosed buy or sell, it has to even if the trade itself is not shown. They argue that massive buys/sells, if revealed could influence the market and that is why the ten day thing is there. If it is a huge buy it would have to be 3 to 6 million I would have thought.

Hope it was!!

All IMHO.

Report, although it recommends the Gendrive machine for "point of care" is NOT. How on earth can NICE say the 1st choice is the lab test? It is a ridiculous conclusion that in fact that I hear has already been complained about. It is scandellous IMHO. The Scottish Health Technologies Group (SHTG) (that advises the Scottish NHS) have effectively concluded the Genedrive machine is the way to go. That is because it quite obviously is.

" ▪ after the first year, **hospital ward-based testing**saved the NHS **£17.6 to £18 million over 5 years**."

"after the first year, hospital ward-based testing (THE GENEDRIVE MACHINE) saved the NHS £17.6 to £18 million over 5 years". Over 5 years saves MORE money than using the lab test, takes an hour rather than many hours, if not days, DOES NOT NEED A BLOOD DRAW. There is NO COMPARISON.

https://shtg.scot/our-advice/clopidogrel-genotype-testing-after-ischaemic-stroke-or-transient-ischaemic-attack-tia/

All IMHO.

https://shtg.scot/our-advice/clopidogrel-genotype-testing-after-ischaemic-stroke-or-transient-ischaemic-attack-tia/

Ask for a better report to recommend the Genedrive machine. It's there in black and white.

Scottish Health Technologies Group.

"Our assessment of the value for money of genetic testing for clopidogrel resistance found that:

▪ genetic testing in laboratories saved the NHS £17.9 million over 5 years, starting in the year it was introduced.

▪ genetic testing on hospital wards cost the NHS money in the year it was introduced.

▪ after the first year, **hospital ward-based testing**saved the NHS **£17.6 to £18 million over 5 years**."

"after the first year, hospital ward-based testing (THE GENEDRIVE MACHINE) saved the NHS £17.6 to £18 million over 5 years". Over 5 years saves MORE money than using the lab test, takes an hour rather than many hours, if not days, DOES NOT NEED A BLOOD DRAW. There is NO COMPARISON.

https://shtg.scot/our-advice/clopidogrel-genotype-testing-after-ischaemic-stroke-or-transient-ischaemic-attack-tia/

All IMHO.

johnlay****

please explain what you mean!

Over 5 years.". Direct quote from the report by the Scottish Health Technologies Group (see link below).

"Our assessment of the value for money of genetic testing for clopidogrel resistance found that:

▪ genetic testing in laboratories saved the NHS £17.9 million over 5 years, starting in the

year it was introduced.

▪ genetic testing on hospital wards cost the NHS money in the year it was introduced.

▪ after the first year, **hospital ward-based testing**saved the NHS **£17.6 to £18 million over

5 years**."

===

This is what the Scottish Health Technologies Group assessment says. HOSPITAL WARD BASED TESTING (i.e. the Genedrive machine) IS CHEAPER FOR SCOTLAND OVER 5 YEARS. Also, no blood draw needed (a tad important), results in about an hour (also very very important). No contest. Obviously the Genedrive machine wins whatever way you look at it.

===

"Genetic testing for clopidogrel resistance saves money because fewer people have another

stroke. As a result, fewer people need hospital treatment and rehabilitation support.".

https://shtg.scot/our-advice/clopidogrel-genotype-testing-after-ischaemic-stroke-or-transient-ischaemic-attack-tia/

About time the market woke up to this. The sp is ludicrously low IMHO.

All IMHO.

Will they be assessing the Genedrive machines like the Scottish one did?

https://healthtechnology.wales/about/

Half am hour from now (posted @ 12:30Pm).

Https://events.teams.microsoft.com/event/3edc46d4-058a-4a96-8c3d-810bddb99c05@ddc77078-e803-4eeb-80ca-dd03ba7459c4

The machine for entire Scottish NHS stroke use, not just "point of care". They assess the machine is the cheapest option for the Scottish NHS. Common sense prevails in Scotland.". My quote from earlier post.

- NHS Scotland info:-

https://en.wikipedia.org/wiki/NHS_Scotland

- Scottish Health Technologies Group assessment of the Genedrive machine:-

https://shtg.scot/our-advice/clopidogrel-genotype-testing-after-ischaemic-stroke-or-transient-ischaemic-attack-tia/

Before the good news, now it's 2.3p to buy!.

What can we expect from this "national update" TOMORROW???

Https://www.genomicseducation.hee.nhs.uk/events/national-update-on-genetic-testing-to-guide-clopidogrel-use-after-ischaemic-stroke-or-transient-ischaemic-attack/

All IMHO.